Press Releases

May 12, 2026
BILLERICA, Mass. --(BUSINESS WIRE)--May 12, 2026-- Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer (“CFO”) will depart the Company.
May 06, 2026
Reports $36.4 million in revenue and approximately $103 million of cash and marketable securities Company prioritizing product roadmap and investing in initiatives to drive commercial effectiveness BILLERICA, Mass. --(BUSINESS WIRE)--May 6, 2026-- Quanterix Corporation   (NASDAQ: QTRX), a company
Apr 24, 2026
BILLERICA, Mass. --(BUSINESS WIRE)--Apr. 24, 2026-- Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Wednesday, May 6, 2026, at 4:30 p.m.
Apr 15, 2026
The Content Innovation Engine brings together Akoya's spatial biology platform and Quanterix's immunoassay infrastructure to systematically unlock cancer biology and accelerate the path toward clinical application BILLERICA, Mass. --(BUSINESS WIRE)--Apr.
Mar 27, 2026
BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 27, 2026-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection (the “Company”), today announced that the Company’s 2026 annual meeting of shareholders (the “Annual Meeting”) will be held
Mar 02, 2026
Reports $43.9 million in revenue and cash balance of $122 million Company expects to achieve cash flow breakeven during 2026 BILLERICA, Mass. --(BUSINESS WIRE)--Mar. 2, 2026-- Quanterix Corporation   (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection,
Feb 26, 2026
BILLERICA, Mass. --(BUSINESS WIRE)--Feb. 26, 2026-- Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its executive leadership team will participate in the following investor
Displaying 1 - 10 of 15